SATB2 International Conference and Clinic

Arkansas Children’s Hospital hosts the only dedicated multidisciplinary clinic for the SATB2-associated syndrome in the world.

2018 SATB2 International Conference and Clinic

The Arkansas Children's Hospital and the SATB2 Gene Foundation, Inc. are excited to announce the 2nd International SATB2-associated syndrome (SAS) conference

June 27 - 29, 2018, Little Rock, Arkansas

Websites: | 

SATB2-associated syndrome (SAS) is a genetic disorder characterized by:

  • developmental delay/intellectual disability with absent or limited speech development
  • behavioral problems
  • abnormalities of the palate (roof of the mouth) and teeth

Changes in the SATB2 gene cause this syndrome. Common types of gene changes are mutations (misspellings), deletions (pieces missing), or duplications (pieces extra) in the SATB2 gene. SAS has also been labeled “Glass syndrome” (OMIM #612313) after Dr. Glass who described a patient with a deletion in chromosome 2 back in 1989. Similarly, other patients with deletions in this area have been labeled “2q33.1 microdeletion syndrome” or “2q32 deletion syndrome”. 

Yuri Zarate, M.D., is a clinical geneticist at Arkansas Children’s Hospital and has initiated a project to collect clinical information on patients with SAS no matter how the SATB2 gene is changed (deletions, duplications, or mutations) to increase knowledge of this condition.

Currently, more than 100 families are enrolled in the study. Parents and clinicians are encouraged to contact Dr. Zarate for further questions and to consider enrollment in his study.

For more information about SATB2, including FAQs, visit:


Dr. Yuri Zarate - SATB2 SpecialistContact

Yuri Zarate, M.D., MBA

Associate Professor, Section of Genetics and Metabolism
University of Arkansas for Medical Sciences
Arkansas Children’s Hospital
1 Children’s Way Slot 512-22
Little Rock, AR 72202
Phone: 501-364-1926
Fax: 501-364-1564